Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
WebMD: FDA expands its partnership with the popular health information Web site WebMD with FDA-sponsored material in five new subject areas: allergies and asthma; children's health; diabetes; heart health; and vitamins and supplements. Clickable sub-topics include items titled "FDA 101: Product Recalls" and "Your Guide to Reporting Problems to FDA." Since its December 2008 launch, WebMD's FDA page has been accessed by more than 150,000 consumers, the agency notes ("1The Gray Sheet" Dec. 8, 2008)
You may also be interested in...
FDA Teams With WebMD For Wider Dissemination Of Product Safety Info
FDA will reach a vastly larger audience for product safety alerts through a new partnership with the popular health information Web site WebMD, announced Dec. 3. The pact could boost the number of patients seeing FDA alerts from 130,000 a month currently to tens of millions
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.